Abstract:Xiaoxue Liu, 1 Maigeng Zhou, 2 Fang Wang, 1 Sumaira Mubarik, 1 Yafeng Wang, 1 Runtang Meng, 1 Fang Shi, 1 Haoyu Wen, 1 Chuanhua Yu 1, 3 1 Department of Epidemiology and Biostatistics, School of Health Sciences, Wuhan University, Wuhan 430071, People's Republic of China; 2 National Center for Chronic and Non-Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 100050, People's Republic of China; 3 Global Health Institute, Wuhan University, Wuhan 430072, People's Republic of China Correspondence: Chuanhua Yu Tel +86-27-6875-8648 Email yuchua@whu.edu.cn Purpose: China has a heavy cancer burden. We aimed to quantitatively estimate the secular trend of cancer mortality and incidence in China. Methods: We extracted numbers, age-specific and age-standardized rates of 29 cancer groups (from 1990 to 2017) from the Global Burden of Disease (GBD) study in 2017. We estimated rates of major cancer types for annual percent change by Joinpoint regression, and for age, period, and cohort effect by an age–period–cohort model. Results: In 2017, breast cancer had the highest incidence rate in females. Lung cancer had the highest mortality and incidence rates in males. Although the age-standardized incidence rate of prostate cancer ranked second highest in males, it increased by 112% from 1990 to 2017. Individuals aged over 50 years were at high risk of developing cancer, and the number of deaths at this age accounted for over 89% of all cancers in all age groups. When compared with the global average level, the age-standardized mortality and incidence rates of both liver and esophageal cancers were 2.1 times higher in China, and stomach, lung and nasopharyngeal cancers in China also had high levels (more than 1.5 times higher). During 1990– 2017, most of the 29 cancers exhibited an increasing incidence trend, and Joinpoint regression demonstrated increasing mortality of some major cancers. The period effect indicated that the risk of mortality and incidence due to the main cancers generally increased during 1992– 2017. Conclusion: Trend analysis provided information on the effects of prevention strategies and targeted interventions on the occurrence of different cancers. Etiological studies need to be conducted on some major cancers in the Chinese population. Keywords: Chinese burden of cancer, mortality and incidence, trend, Joinpoint analysis, age–period–cohort analysis

Secular trends of morbidity and mortality of prostate, bladder, and kidney cancers in China, 1990 to 2019 and their predictions to 2030

[Changes in the disease burden of male urinary and reproductive system tumors in China from 1990 to 2019: Analysis with a prediction of the future trend]

Global and Regional Incidence, Mortality Trends and Predictions of Urologic Cancer, 1990-2026: A Systematic Analysis of the Global Burden of Disease Study 2016

Estimates of over-time trends in incidence and mortality of prostate cancer from 1990 to 2030

Mortality Trends of Bladder Cancer in China from 1991 to 2015: an Age-Period-cohort Analysis

Temporal trends of bladder cancer incidence and mortality from 1990 to 2016 and projections to 2030

Trends and Age-Period-cohort Effect on Incidence and Mortality of Prostate Cancer from 1990 to 2017 in China.

Age-specific incidence trends of 32 cancers in China, 1983 to 2032: Evidence from Cancer Incidence in Five Continents

Changing Patterns in Cancer Mortality from 1987 to 2020 in China

Trends in cancer mortality among the elderly in China, 2005-2035

Temporal trends of kidney cancer incidence and mortality from 1990 to 2016 and projections to 2030

Future of Cancer Incidence in Shanghai, China: Predicting the Burden Upon the Ageing Population

Prognosis of Prostate Cancer and Bone Metastasis Pattern of Patients: a SEER-based Study and a Local Hospital Based Study from China

Trends and age-period-cohort effects on mortality of the three major gynecologic cancers in China from 1990 to 2019: Cervical, ovarian and uterine cancer

Secular Trend of Cancer Death and Incidence in 29 Cancer Groups in China, 1990–2017: A Joinpoint and Age–Period–Cohort Analysis

Temporal trends and projections of gynecological cancers in China, 2007–2030

Estimates of over-time trends in incidence and mortality of testicular cancer from 1990 to 2030

Liver cancer incidence and mortality in China: Temporal trends and projections to 2030

The epidemic of thyroid cancer in China: Current trends and future prediction

Trends and risk factors of global incidence, mortality, and disability of genitourinary cancers from 1990 to 2019: Systematic analysis for the Global Burden of Disease Study 2019

Global burden of benign prostatic hyperplasia, urinary tract infections, urolithiasis, bladder cancer, kidney cancer, and prostate cancer from 1990 to 2021